|
1
|
Chan KC, Hung EC, Woo JK, Chan PK, Leung
SF, Lai FP, Cheng AS, Yeung SW, Chan YW, Tsui TK, et al: Early
detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus
DNA analysis in a surveillance program. Cancer. 119:1838–1844.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marsh GM, Youk AO and Morfeld P:
Mis-specified and non-robust mortality risk models for
nasopharyngeal cancer in the National Cancer Institute formaldehyde
worker cohort study. Regul Toxicol Pharmacol. 47:59–67. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang B and Tang PZ: Introduction to ‘NCCN
clinical practice guidelines in head and neck cancer (2009 Chinese
version)’. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
44:707–709. 2009.(In Chinese). PubMed/NCBI
|
|
4
|
Lee N, Harris J, Garden AS, Straube W,
Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et
al: Intensity-modulated radiation therapy with or without
chemotherapy for nasopharyngeal carcinoma: Radiation therapy
oncology group phase II trial 0225. J Clin Oncol. 27:3684–3690.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen J, Zong J, Wu J and Pan J: Prognostic
analysis of nasopharyngeal carcinoma patients with distant
metastasis after curative radiotherapy. Zhonghua Zhong Liu Za Zhi.
37:216–221. 2015.(In Chinese). PubMed/NCBI
|
|
6
|
Lin Y, Ukaji T, Koide N and Umezawa K:
Inhibition of late and early phases of cancer metastasis by the
NF-κB inhibitor DHMEQ derived from microbial bioactive metabolite
epoxyquinomicin: A review. Int J Mol Sci. 19:192018. View Article : Google Scholar
|
|
7
|
Engels BM and Hutvagner G: Principles and
effects of microRNA-mediated post-transcriptional gene regulation.
Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie YJ, Long ZF and He XS: Involvement of
EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in
nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev.
14:5637–5644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using realtime quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao Z, Ching Chow S, Han Li C, Chun Tang
S, Tsui SK, Lin Z and Chen Y: Role of microRNA-95 in the anticancer
activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol.
728:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang G, Mao W and Zheng S: MicroRNA-183
regulates Ezrin expression in lung cancer cells. FEBS Lett.
582:3663–3668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang R, Li FX, Shao WF, Wen QS, Yu XR and
Xiong JB: Protein-protein interaction between ezrin and p65 in
human breast cancer cells. Genet Mol Res. 15:152016. View Article : Google Scholar
|
|
17
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by
microRNA 183. J Biol Chem. 285:5461–5471. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J,
Qin Y, Sun Z and Zheng X: miR-183 inhibits TGF-beta1-induced
apoptosis by downregulation of PDCD4 expression in human
hepatocellular carcinoma cells. BMC Cancer. 10:3542010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim J, Kang HS, Lee YJ, Lee HJ, Yun J,
Shin JH, Lee CW, Kwon BM and Hong SH: EGR1-dependent PTEN
upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion
and EMT in colon cancer. Cancer Lett. 349:35–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng F, Li Z, Yan J, Manjanatha M, Shelton
S, Yarborough S and Chen T: Tissue-specific microRNA responses in
rats treated with mutagenic and carcinogenic doses of aristolochic
acid. Mutagenesis. 29:357–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Jaarsveld MT, Helleman J, Boersma AW,
van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH,
Berns EM, Verweij J, et al: miR-141 regulates KEAP1 and modulates
cisplatin sensitivity in ovarian cancer cells. Oncogene.
32:4284–4293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xue J, Niu YF, Huang J, Peng G, Wang LX,
Yang YH and Li YQ: miR-141 suppresses the growth and metastasis of
HCC cells by targeting E2F3. Tumour Biol. 35:12103–12107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmed FE, Amed NC, Vos PW, Bonnerup C,
Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE and Allison RR:
Diagnostic microRNA markers to screen for sporadic human colon
cancer in blood. Cancer Genomics Proteomics. 9:179–192.
2012.PubMed/NCBI
|
